Alstembio蚂蚁淘在线

商品

品牌

文章

热门搜索：

快报

蚂蚁淘特色产品FLOWTECH造影剂蚂蚁淘授权代理品牌-德国Emfret 蚂蚁淘旗下188精品现货平台正式上线啦！！！蚂蚁淘四月促销蚂蚁淘获得vitanavitech代理商授权蚂蚁淘获得QA-bio代理商授权蚂蚁淘获得Viagenbiotech代理商授权 polysciences公司24765-1到现货了(内附代理商整理说明书）蚂蚁淘四月团建“环苏州古城一周” Clodronate Liposomes用量更正！

品牌首页品牌新闻品牌简介产品中心品牌咨询联系我们

品牌分类

品牌咨询

联系方式

公司地址

苏州工业园区生物纳米园A4#216

联系电话

4000-520-616 / 18915418616

传真号码

0512-67156496

电子邮箱

info@ebiomall.com

公司网址

https://www.ebiomall.com

蚂蚁淘在线 / 品牌中心 / Alstembio / Alstembio/HumanipCell重新编程EPIOMALKIT/RF202

Alstembio/HumanipCell重新编程EPIOMALKIT/RF202

价格

￥12500.00

货号：RF202

浏览量：127

品牌：Alstembio

服务

全国联保

正品保证

正规发票

签订合同

加入收藏

立即购买

商品描述

EpisomaliPSCReprogrammingKit:#RF202

ProductDescription

ThehumanepisomaliPSCreprogrammingkitfromALSTEMisoneofthebestchoicesforproducingfootprint-freeiPSCs,providingasourceofiPSCsforallstagesofyourpluripotentstemcellresearch.OptimizedbytheALSTEMteam,thisepisomalkithasproventobesuccessfulininducingpluripotencyinanumberofdifferentsomaticcelltypes.

Features

Generatetransgene-free,virus-free,andfootprint-freeiPScells
Episomalkitforhumaninducedpluripotentstemcell(iPSC)generation
Safeforallstagesofyourresearchfrombasicresearchtopre-clinicalresearch
FlexIBLeinsourcecellselection
Enhancedreprogrammingefficiencybypuromycinselection
Optimizedforfeeder-freereprogramming
Additionofsmallmoleculesarenotrequired

OptimizeReprogrammingwithPuromycinSelection

Figure2.(A)AtypicalimageofthehumandermalfibroblaststransfectedwithRFPusingNeonTransfectionDevices(24hoursafterelectroporation).~30%offibroblastsareRFPpositive.(B)Afterpuromycinselection,morethan90%offibroblastsareexpressingRFP(~5daysafterpuromycinselection).

Figure1.CharacterizationofiPSCsderivedfromhumandermalfibroblastsusingALSTEMepisomalvectors.BrightfieldimageofhiPSCcolonies(topleft),immunostainingofhiPSCcoloniesexpressingESCspecificMarkersOCT4,SSEA-3,andTRA-1-81.

ProductSpecifications
ProductName	HumaniPSCellReprogrammingEpisomalKit
Catalog#	RF202
Component	hiPSCReprogrammingEpisomalVectors(cat.no.RF202_1) RFPControlVector(cat.no.RF202_2): Eachkitcontainssufficientmaterialfor10reprogrammingexperiments
Shipping	Ambienttemperature
StorageandStABIlity	Storeat-20°Cuponreceipt.Thisproductisstableupto6monthswhenstoredasdirected.
QualityControl	EachlotofHumaniPSCellReprogrammingEpisomalKitistestedtoensurehumanfibroblastscanbereprogrammedtoiPSCs.
RestrictedUse	ForResearchUseOnly.Notforuseindiagnosticortherapeuticprocedures.
Protocol	Download

Overview
Procedure

Description

Inducedpluripotentstemcells(iPSCs)aregeneticallyreprogrammedfromadultcells,whicharesimilartonaturalpluripotentstemcells,suchasembryonicstemcells(ESCs).iPSCsexhibitapluripotentstemcell-likestate,suchastheexpressionofcertainstemcellgenesandproteins,chromatinmethylationpatterns,teratomaformation,andpotencyanddifferentiability.Whiletheseartificiallygeneratedcellsarenotknowntoexistinthehumanbody,theyshowqualitiesremarkablysimilartothoseofembryonicstemcells.Therefore,iPSCsareaninvaluableresourcefordrugdiscovery,celltherapy,andbasicresearch.

HumaniPSCswerefirstgeneratedin2007throughretrovirus-orlentivirus-mediatedgenetransduction.However,retroviralorlentiviralvectorsrequireintegrationintohostchromosomestoexpressreprogramminggenes.Integration-freehumaniPSCshavebeengeneratedusingseveralmethods,includingadenovirus,Sendaivirus,thepiggyBacsystem,minicirclevector,episomalvectors,directproteindeliveryandsynthesizedmRNA.Thereprogrammingefficiencyoftheseintegration-freemethodsisimpracticallylowinmostcases.DirectdeliveryofproteinsorRNAislabor-intensive,requiringrepeateddeliveryofthereprogrammingfactors.ModifyingSendaivirusvectorsorpreparingsynthesizedmRNAsaretechnicallydemanding.

TheHumaniPSCellReprogrammingEpisomalKitisanoptimizedmixtureofmultiplevectorsthatcanreprogramsomaticcellstoiPSCswithoutintegration.TheepisomalvectorshavetheoriP/EBNA-1(Epstein-Barrnuclearantigen-1)backbonethatdeliversthereprogrammingfactorsaswellaspuromycinresistantgene.Thissystemhasbeensuccessfullydemonstratedinreprogrammingoffibroblasts,aswellasotheradultcells,toiPSCS.HighexpressionoftransgenesduetooriP/EBNA-1mediatednuclearimportandretentionofvectorDNAallowsiPSCderivationinasingletransfection.Thereprogrammingefficiencyisfurtherenhancedbypuromycinselection.Inaddition,silencingoftheviralpromoterwhichdrivesEBNA-1expressionandthelossoftheepisomesatarateof~5%percellcycleduetodefectsinvectorsynthesisandpartitioningallowstheremovalofepisomalvectorsfromtheiPSCswithoutanyadditionalmanipulation.

ForoptimalreprogrammingwiththeHumaniPSCellReprogrammingEpisomalKit,culturethefibroblastsinFibroblastMediumuntilthedayoftransfection.Aftertransfection,allowthecellstorecoverinFibroblastMediumfor24hours,andthenaddpuromycintoremovetheuntransfectedcells.Reseedthecellsonfeedersabout5daysposttransfection,andswitchtheculturemediumtohESCculturemediumnextday.Thisreprogrammingprotocolisverysimpleandtheeffective.PD0325901,CHIR99021,A-83-01,hLIF,orHA-100isnotrequiredforreprogramming.

CreateYourOwnFootprint-freeiPSCells

HumaniPSCellReprogrammingEpisomalKitisacost-effectiveplasimdmixofmultipleepisomalvectorswhichencodefourreprogrammingfactors.Otherreprogrammingmethods,suchaslentivirusandretrovirus,containtransgenesthatcanintegrateintothehostgenome,potentiallydisruptingthegenomeorcausingunpredictableresults.Thisepisomalmixisabletoefficientlygeneratetransgene-free,virus-freeandfootprint-freeinducedpluripotentstemcells(iPSCs)inbothfeederandfeeder-freeconditions.OptimizedbyALSTEMteam,thisepisomalmixhasproventobesuccessfulininducingpluripotencyforanumberofdifferentsomaticcelltypes.

Theseepisomalvectorsareintroducedintothecellbyelectroporation.AsoriP/EBNA1vectors,theycontainallthereprogrammingfactorsandreplicateextrachromosomallyonlyoncepercellcycle.Atthisreplicationrate,theepisomesarelostatarateofapproximately5%percellgeneration.

GenerateiPSCLinesfromaWideVarietyofSomaticCellTypes

iPScellshavebeengeneratedbyepisomalvectorsfromarangeofsomaticcellsincludingfibroblasts,bonemarrowmononuclearcells,PBMCs,lymphoblastBcells,andvariousdisease-typefibroblastsandPBMCs.Eachkitprovidesenoughmaterialfor10reprogrammingexperiments.

Thefollowingprotocolhasbeenoptimizedforhumandermalfibroblastcells.Werecommendthatyouoptimizetheprotocolforyourcelltype.

I.Feeder-FreeReprogrammingProtocol

Day-1:SeedCells

1.Seed1x10⁶humanfibroblastsinagelatincoatedT75flask.Cellsshouldreachapproximately75–90%confluenceonthedayoftransfection(Day0).

Day0:NucleofectionofEpisomalPlasmidstoHumanFibroblasts

2.PreparetheNeonTransfectionDevicesandkits(using10µltipsinthisprotocol).

3.Preparethegelatin-coated6wellplateandwarmupFibroblastMedium(w/oP/S)intheplate.

4.AspiratethemediumfromthefibroblastsintheT75flask,andwashthecellswithDPBSwithoutcalciumandmagnesium.Add2mlof0.05%Trypsin/EDTAtotheflask,andincubatetheflaskat37°Cfor3minutes.

5.Add5mlofFibroblastMediumtotheflask.Taptheflasktoensurethecellsaredislodgedfromtheflask,andcarefullytransferthecellsintoanew15-mlconicaltube.Spindowncellsat1,000rpmfor5minutesatroomtemperature.

6.ResUSPendthecellsin2mlofDPBS.Countthecells,andthentake3x10⁵cellsintoeach1.5mltubefortwotubes.

Note:Youneed3x10⁵cellsforonetransfection,andthecellnumbercanbemodifiedto1.5–6x10⁵cellspertransfection.

7.Spindownthecellsat2000rpmfor5minatroomtemperature.Inthemeantime,add3mlofsolutionE2tothemicroporationtube,andmix1.5µgofreprogrammingvectorsinone1.5mltubewithe10µlSolutionR.Inanothertube,mix0.5µgforRFPcontrolwith10µlSolutionR.

Note:Ifyouuse100-µltip,mix3µgofreprogrammingvectorsin100µlSolutionRand1µgforRFPcontrolin100µlSolutionR,respectively.

8.Carefullyaspiratemostofthesupernatant.ResuspendthecellpelletinSolutionRwithplasmids.

9.TurnontheNeonunitandentertheelectroporationparametersintheInputwindowto1,650Voltsofpulsevoltage,10msofpulsewidth,and3pulses.

Note:Toincreasetheviability,youmayusetheelectroporationparametersof1,400Voltsofpulsevoltage,30msofpulsewidth,and1pulse.

10.Pressthepush-buttonontheNeon®PipettetothefirststopandimmersetheNeon®Tipintothecell-DNAmixture.Slowlyreleasethepush-buttononthepipettetoaspiratethecell-DNAmixtureintotheNeon®Tip.

Note:Avoidairbubbleswhenpipettingtoavoidarcingduringelectroporation.Ifyounoticeairbubblesinthetip,discardthesampleandcarefullyaspiratefreshsampleintothetipagainwithoutanyairbubbles.

11.InserttheNeon®PipettewiththesampleverticallyintotheNeon®TubeplacedintheNeon®PipetteStationuntilyouhearaclick.EnsurethatyouhaveenteredtheappropriateelectroporationparametersandpressStartontheNeon®touchscreentodelivertheelectricpulse.

12.Immediatelyafterelectroporation,thecellsuspensionsolutionispouredintowarmFibroblastMedium(w/oP/S)inonewellofa6-wellplatepre-coatedwithgelatin.Culturetheelectroporatedcellsin37°C,5%CO₂incubator.

Day1,3,5:ChangetheFbroblastMedium

13.ChangemediumtoFibroblastMediumwithP/S,supplementedwith0.5µg/mlofpuromycin.

Note:IfRFPplasmidisusedtomonitorthetransfectionefficiency,theRFPexpressioncanbedetectedduringthesedays.Byaddingpuromycin,nonpuro-resistantcellsdislodge.

Note:DoNOTtreattransfectedcellswithpuromycinmorethanthreedays.

Day6:ReplatingtheTransfectedCells

14.Aspiratethemediumoftransfectedfibroblasts,andwashthecellsinDPBSwithoutcalciumandmagnesium.Add0.5mlof0.05%Trypsin/EDTAtothewell,andIncubatetheplateat37°Cfor2minutes.

15.Add1mlofFibroblastMediumtothewell.Taptheplatetoensurecellsaredislodgedfromtheplate,andcarefullytransferthecellsintoanew15-mlconicaltube.Spindownthecellsat1,000rpmfor5minutesatroomtemperature.

16.Resuspendthecellsin2mlofFibroblastMedium.Countthecells.Seed1x10⁴,2x10⁴,and4x10⁴transfectedfibroblasts,respectively,inthewellsofa6-wellplatecoatedwithMatrigel.

Note:Thecellnumberscanbechangedfrom0.5-3x10⁵cellswhenusinga100-mmdish.Theseedingdaycanvaryaccordingtothecells.

Day7:SwitchtoiPSGenmedium

17.Aspiratethemediumofthereprogrammingfibroblasts,andadd2mlofiPSGenMedium(StemRD).

18.Changethemediumeverydayuptoday14.

Day14:SwitchtoPSGro/mTeSR1medium

19.Aspiratethemediumofthereprogrammingfibroblasts,andadd2mlofPSGro/mTeSR1medium.

20.ChangePSGro/mTeSR1mediumeveryday.

Day24–30:PickingiPS-likecolonies

ByDay24ofpost-transfection,thecellcoloniesintheMatrigel-coatedplatesconsistofiPSCs,whichexhibitahESC-likemorphologycharacterizedbyaflatter,cobblestone-likeappearancewithindividualcellsclearlydemarcatedfromeachotherinthecolonies.

21.Examinetheplatecontainingthereprogrammedcellsunder10Xmagnificationofaninvertedmicroscope,andmarkthecolonytobepickedatthebottomoftheplate.

Note:Werecommendpickingatleast10distinctcoloniesbytheendofeachreprogrammingexperimentandexpandingtheminseparate24-wellMatrigel-coatedplate.

22.Transfertheplatetoabiosafetycabinetequippedwithastereomicroscope.

23.Cutthecolonytobepickedinto5–6piecesinagrid-likepatternusinga25-gauge1½inchneedle.

24.Usinga200-µLpipette,transferthecutpiecestoafreshlypreparedMatrigel-coatedwellofa24-wellplatecontainingmTeSR1mediumsupplementedwith10µMROCKinhibitor(Y-27632,StemRD).

25.IncubatetheMatrigel-coatedplatecontainingthepickedcoloniesina37°C,5%CO₂incubator.

26.Allowthecoloniestoattachtothecultureplatefor48hoursbeforereplacingthespentmediumwithfreshmTeSR1medium.Sincethen,changethemediumeveryday.

27.CulturethereprogrammedcolonieslikenormalhumaniPSCcolonies;expandandmaintainthemusingstandardcultureprocedures.

Note:NewlyderivediPSClinesmaycontainafairamountofdifferentiationthroughpassage4.Itisnotnecessarytoremovedifferentiatedmaterialpriortopassaging.Bypropagatingthecellstheoverallculturehealthshouldimprovethroughouttheearlypassages.Otherwise,pickuptheiPS-likecoloniesandcultureinMatrigelcoated24-wellplate.

II.ReprogrammingProtocolUsingMEFFeeders

Day-1:SeedCells

1.Seedhumanfibroblastsat1x10⁶cellsinagelatincoatedT75flask.Cellsshouldreachapproximately75–90%confluenceonthedayoftransfection(Day0).

Day0:NucleofectionofEpisomalPlasmidstoHumanFibroblasts

2.PreparetheNeonTransfectionDevicesandkits

3.Preparethegelatin-coated6wellplatesandwarmupFibroblastMedium(w/oP/S)intheplates.

4.AspiratethemediumfromthefibroblastsintheT75flask,andwashthecellswithDPBSwithoutcalciumandmagnesium.Add2mlof0.05%Trypsin/EDTAtotheflask,andincubatetheflaskat37°Cfor3minutes.

5.Add5mlofFibroblastMediumtotheflask.Taptheflasktoensurethecellsaredislodgedfromtheflask,andthencarefullytransferthecellsintoanew15-mlconicaltube.Spindowncellsat1,000rpmfor5minutesatroomtemperature.

6.Resuspendthecellsin2mlofDPBS.Countthecells,andtake3x10⁵cellsintoeach1.5mltubefortwotubes.

Note:Youneed3x10⁵cellsforonetransfection,andthecellnumbercanbemodifiedto1.5–6x10⁵cellspertransfection.

7.Spindownthecellsat2000rpmfor5minutes.Inthemeantime,add3mlofsolutionE2tothemicroporationtube,andmix1.5µgofreprogrammingvectorsinone1.5mltubewith10µlSolutionR.Inanothertube,mix0.5µgforRFPcontrolwith10µlSolutionR.

Note:Ifyouuse100-µltip,mix3µgofreprogrammingvectorsin100µlSolutionRand1µgforRFPcontrolin100µlSolutionR,respectively.

8.Carefullyaspiratemostofthesupernatant,andresuspendthecellpelletinSolutionRwithplasmids.

9.TurnontheNeonunitandentertheelectroporationparametersintheInputwindowto1,650Voltsofpulsevoltage,10msofpulsewidth,and3pulses.

Note:Toincreasetheviability,youmayusetheelectroporationparametersof1,400Voltsofpulsevoltage,30msofpulsewidth,and1pulse.

10.Pressthepush-buttonontheNeon®PipettetothefirststopandimmersetheNeon®Tipintothecell-DNAmixture.Slowlyreleasethepush-buttononthepipettetoaspiratethecell-DNAmixtureintotheNeon®Tip.

Note:Avoidairbubbleswhenpipettingtoavoidarcingduringelectroporation.Ifyounoticeairbubblesinthetip,discardthesampleandcarefullyaspiratefreshsampleintothetipagainwithoutanyairbubbles.

12.Immediatelyafterelectroporation,thecellsuspensionsolutionispouredintowarmFibroblastMedium(w/oP/S)inonewellofa6-wellplatepre-coatedwithgelatin.Culturetheelectroporatedcellsin37°C,5%CO₂incubator.

Day1,3,5:ChangetheFibroblastMedium

13.ChangemediumtoFibroblastMediumwithP/S,supplementedwith0.5µg/mlofpuromycin.

Note:IfRFPplasmidisusedtomonitorthetransfectionefficiency,theRFPexpressioncanbedetectedduringthesedays.Byaddingpuromycin,nonpuro-resistantcellsdislodge.

14.Onday5,seedtheMEF/SNLcellsinagelatin-coateddishes(5x10⁵cellsperwellofa6-wellplateor3x10⁶cellsper100-mmdish).

Day6:ReplatingtheTransfectedCells

15.Aspiratethemediumofthetransfectedfibroblasts,andwashthecellsinDPBSwithoutcalciumandmagnesium.Add0.5mlof0.05%Trypsin/EDTAtothewell.Incubatetheplateat37°Cfor2minutes.

16.Add1mlofFibroblastMediumtothewell.Taptheplatetoensurecellsaredislodgedfromtheplate,andcarefullytransferthecellsintoanew15-mlconicaltube.Spindownthecellsat1,000rpmfor5minutesatroomtemperature.

17.Resuspendthecellsin2mlofFibroblastMedium.Countthecells.Seed1x10⁴,2x10⁴,and4x10⁴transfectedfibroblasts,respectively,ontothewellsofa6-wellplatepre-seededMEF/SNLfeedercells.

Note:Thecellnumberscanbechangedfrom5x104to3x105cellswhenusinga100-mmdish.Theseedingdaycanvaryaccordingtothecelltypes.

Day7:SwitchtohESMedium

18.Aspiratethemediumofthereprogrammingfibroblasts,andadd2mlofhESMediumsupplementedwith10ng/mlofbFGF.

19.Changethemediumeverydayuptoday15.

Day16:SwitchtohES/PSGroMedium

20.Aspiratethemediumofthereprogrammingfibroblasts,andadd2mlofhES/PSGroMedium.

Note:YoumayalsousemTeSR1(StemcellTechnologies)orEssential8Medium(LifeTechnologies)toreplacePSGromedium(StemRD).

21.ChangehEC/PSGroMediumeveryday.

Figure2.ExpectedmorphologyofemergingiPSCsduringepisomalreprogrammingofhumandermalfibroblastsastheyundergomorphologicalchangesandiPSCcoloniesbegintoemerge.

Day21–30:PickingiPS-likecolonies

ByDay21ofpost-transfection,thecellcoloniesintheMEFplateconsistofiPSCs,whichexhibitahESC-likemorphologycharacterizedbyaflatter,cobblestone-likeappearancewithindividualcellsclearlydemarcatedfromeachotherinthecolonies(seeFigure2).

22.Examinethecultureplatecontainingthereprogrammedcellsunder10Xmagnificationofinvertedmicroscope,andmarkthecolonytobepickedatthebottomofthecultureplate.

Note:Werecommendpickingatleast10distinctcoloniesbytheendofeachreprogrammingexperimentandexpandingtheminseparate24-wellMEFplate(orMatrigel-coatedplate).

23.Transferthecultureplatetoabiosafetycabinetequippedwithastereomicroscope.

24.Cutthecolonytobepickedinto5–6piecesinagrid-likepatternusinga25-gauge1½inchneedle.

25.Usinga200-µLpipette,transferthecutpiecestoafreshlyprepared24-wellMatrigel-coatedplatecontainingmTeSR1mediumsupplementedwith10µMROCKinhibitor(Y-27632,StemRD).

26.Culturepickedcoloniesina37°C,5%CO₂incubator.

27.Allowthecoloniestoattachtothecultureplatefor48hoursbeforereplacingthespentmediumwithfreshmTeSR1medium.Sincethen,changethemediumeveryday.

28.CulturethereprogrammedcolonieslikenormalhumaniPSCcolonies;expand,andmaintainthemusingstandardcultureprocedures.

Figure3.ALSTEMhiPSCepisomalreprogrammingkitprovideshighreprogrammingefficiency.Alkalinephosphatase(AP)positiveiPSCcolonieswithtypicalhumanESCmorphologywerecountedonday24-27post-transfection.ThenumberofiPSCcolonieswasfrom1x104transfectedcells.

Alstembio定制病毒包装慢病毒包装请求（Web表单）逆转录病毒打包请求（Web表单）我们提供快速的慢病毒和逆转录病毒包装服务，以使用您的病毒构建体生产高质量，高滴度的病毒颗粒，周转时间为1-2周。节省您自己准备病毒的时间和精力，并获得随时可以转导的病毒颗粒。我们的包装服务的特点：周转时间： 10个工作日或更少质量：符合国家卫生研究院《生物安全2级》标准的一流BSL-2设备中的病毒生产，并具有严格的质量控制滴度测量：通过qPCR确定的准确病毒滴度，以测量每毫升感染单位（IFU / ml）所需材料：如果您打算准备自己的DNA，我们要求您提供10-400 µg DNA，具体取决于所需的滴度和体积可交付成果：对于100 µl的体积，我们提供5 x 20 µl的病毒颗粒等分试样，对于200 µl的体积，我们提供10 x 20 µl的等分试样。也可以使用其他配置。

资质认证

获得国家资质，权威认证！
全国联保

全国联保，官方无忧售后
正规发票

正规发票，放心购买
签订合同

签订合同，保障您的权益

/**/